Dr. Ahmed Galal, MD

Dr. Galal practices at The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health.

Dr. Galal's NPI, 1902179906, was assigned on February 22, 2012. Dr. Galal graduated from Ain Shams University Faculty of Medicine in 1985. Dr. Galal holds South Dakota license 8256.

Dr. Galal's primary practice is The Jewish Hospital - Mercy Health, at 4777 East Galbraith Road, Cincinnati, OH 45236 in Hamilton County. The practice phone is (513) 686-3000.

Dr. Galal's primary practice is The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health. Dr. Galal is also affiliated with Morristown Medical Center. The medical group on file is OHC - Oncology Hematology Care. Dmand AI also links Dr. Galal to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galal practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Galal's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Galal's licenses on file in 3 states: South Dakota, New Jersey and North Carolina.

Dmand AI lists chronic anemia, chronic leukemia and lymphoma among the conditions Dr. Galal treats.

CMS data shows 303 Medicare services from Dr. Galal across 8 procedure codes in 2024, for 152 Medicare patients. Medicare paid $32,228 for them.

CMS counts 152 Medicare patients who saw Dr. Galal in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galal's median patient age at 69, with 48% women.

In 2024, Dr. Galal wrote 256 Medicare Part D claims for 54 patients. 50% of them were for generic drugs. CMS names the drug for 141 of them, across 3 drugs with 11 or more claims each, at $1,625,265 in total drug cost. In 2023, CMS named 317 claims across 14 drugs.

Dr. Galal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Galal, published from 2015 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Bone Marrow, Leukemia, Myelogenous, Chronic, BCR-ABL Positive and Protein Kinase Inhibitors. Dr. Galal's most frequent co-authors are Chenyu Lin, MD, Nausheen Ahmed, MD and Evandro D. Bezerra, MD.

Dmand AI links Dr. Galal to 2 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Mantle-Cell and Lymphoma, Large B-Cell, Diffuse.

CMS Open Payments shows 1,885 general payments to Dr. Galal from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $1,084,495.

Dr. Galal graduated from Ain Shams University Faculty of Medicine in 1985.

Dr. Galal is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross and Blue Shield of North Carolina. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.